| 000 | 01289 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250517111101.0 | ||
| 264 | 0 | _c20170922 | |
| 008 | 201709s 0 0 eng d | ||
| 022 | _a1365-2265 | ||
| 024 | 7 |
_a10.1111/cen.13172 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRamchand, Sabashini K | |
| 245 | 0 | 0 |
_aAdjuvant endocrine therapy in women with oestrogen-receptor-positive breast cancer: how should the skeletal and vascular side effects be assessed and managed? _h[electronic resource] |
| 260 |
_bClinical endocrinology _cNov 2016 |
||
| 300 |
_a689-693 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xadverse effects |
| 650 | 0 | 4 | _aBody Composition |
| 650 | 0 | 4 |
_aBone Resorption _xetiology |
| 650 | 0 | 4 |
_aBreast Neoplasms _xcomplications |
| 650 | 0 | 4 |
_aChemotherapy, Adjuvant _xadverse effects |
| 650 | 0 | 4 | _aDisease Management |
| 650 | 0 | 4 |
_aEstradiol _xdeficiency |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLipid Metabolism |
| 650 | 0 | 4 | _aReceptors, Estrogen |
| 700 | 1 | _aLim, Elgene | |
| 700 | 1 | _aGrossmann, Mathis | |
| 773 | 0 |
_tClinical endocrinology _gvol. 85 _gno. 5 _gp. 689-693 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/cen.13172 _zAvailable from publisher's website |
| 999 |
_c26303071 _d26303071 |
||